Yale Uses Zebrafish to Find Personalized Autism Treatments

Yale researchers created a groundbreaking database of 520 FDA-approved drugs by studying tiny zebrafish, revealing potential personalized treatments for people with specific autism-related genetic mutations.

One drug candidate successfully reversed disrupted behaviors in both fish and human brain cells.